Evaluation of adropin, fibroblast growth factor-1 (FGF-1), and Toll-like receptor-1 (TLR1) biomarkers in patients with inflammatory bowel disease: gene expression of TNF-α as a marker of disease severity

Bibliographic Information
Authors: Zaki M.; Orban H.A.; Mahmoud M.; Youness E.R.; Booles H.F.; Khalil W.K.B.; Wafy W.; El-Atrebi K.A.; Hamed K.; El-Bassyouni H.T.
Journal: Egyptian Journal of Medical Human Genetics
Publisher: Springer Nature
Publication Date: 5 June 2024
Volume / Issue: Volume 25 / Issue 1
Article No.: 63
ISSN: 11108630
DOI: 10.1186/s43042-024-00533-2
Scopus: View on Scopus
Document Type: Article
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
Zaki M., Biological Anthropology Department, Medical Researches and Clinical Studies Institute– National Research Centre Cairo, Cairo, Egypt; Orban H.A., Medical Biochemistry Department, Medical Researches and Clinical Studies Institute– National Research Centre Cairo, Cairo, Egypt; Mahmoud M., Medical Biochemistry Department, Medical Researches and Clinical Studies Institute– National Research Centre Cairo, Cairo, Egypt; Youness E.R., Medical Biochemistry Department, Medical Researches and Clinical Studies Institute– National Research Centre Cairo, Cairo, Egypt; Booles H.F., Department of Cell Biology, National Research Centre, Cairo, Egypt; Khalil W.K.B., Department of Cell Biology, National Research Centre, Cairo, Egypt; Wafy W., Public Health, Theodor Bilharz Research Institute, Imbaba, Giza, 12411, Egypt; El-Atrebi K.A., General Medicine and Hepatology Department, National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt; Hamed K., Clinical Genetics Department, National Research Centre, El-Tahreer Street, Dokki, Cairo, Egypt; El-Bassyouni H.T., Clinical Genetics Department, National Research Centre, El-Tahreer Street, Dokki, Cairo, Egypt
Abstract
Background: Inflammatory bowel disease (IBD) is a chronic relapsing inflammatory disorder of unknown etiology and unpredictable course. The aim of the work was to assess the levels of adropin, fibroblast growth factor-1 (FGF-1), and Toll-like receptor-1 (TLR1) biomarkers in IBD patients compared to controls and evaluate the gene expression of TNF-α as a marker of disease severity. Methods: Adropin, fasting serum FGF-1 levels, TLR1, and TNF-α were measured in 60 IBD patients. They were also compared with 58 healthy controls matching age and gender. Moreover, the blood cells cDNA copy number of TNF-α were determined as a marker of severity. Results: Adropin and TLR1 levels were significantly lower in patients than controls. FGF-1 was reduced but not statistically significant. The expression of TNF-α gene in the IBD patients was significantly increased (42%) in comparison with control samples (P < 0.001). Conclusions: Adropin, IGF-I, and Toll-like receptor-1 biomarkers may have a role in the intricate pathophysiology of IBD and may possibly operate as predictors of disease activity. Thus, they may be therapeutic targets for IBD. Moreover, the expression of TNF-α gene can be used as a marker of severity. © The Author(s) 2024.
Keywords
Adropin; cDNA; FGF-1; Inflammatory bowel disease; TLR1; biological marker; complementary DNA; fibroblast growth factor 1; peptide hormone; RNA directed DNA polymerase; toll like receptor 1; tumor necrosis factor; unclassified drug; abdominal pain; adult; arthritis; Article; bleeding; blood level; blood sampling; body weight loss; consanguinity; controlled study; denaturation; depression; diarrhea; digestive system function disorder; disease severity; enzyme linked immunosorbent assay; evaluation study; fasting; female; gene expression; human; major clinical study; male; pedigree analysis; real time polymerase chain reaction; reverse transcription; spectrophotometry; vomiting
Citation Information
Scopus Citations: 3
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
